Evidence map›Paper›PMID 26659221›Full record

ArticleThe oncologist2016

A Multidisciplinary Breast Cancer Brain Metastases Clinic: The University of North Carolina Experience.

Megan J McKee, Kevin Keith, Allison M Deal, Amy L Garrett, Amy A Wheless, Rebecca L Green, Julie M Benbow, E Claire Dees, Lisa A Carey, Matthew G Ewend and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in The oncologist, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Article
  3. Navigating the Complexities of Brain Metastases Management.American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting · 2024
    Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Observational
  12. Article
  13. Article
  14. Enhancing Career Paths for Tomorrow's Radiation Oncologists.International journal of radiation oncology, biology, physics · 2019
    Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Megan J McKeeAtlanta Cancer Care, Atlanta, Georgia, USA University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, USA Department of Medicine, University of North Carolina, Chapel Hill, Chapel Hill, North Carolina, USA.
Kevin KeithUniversity of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, USA.
Allison M DealUniversity of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, USA.
Amy L GarrettUniversity of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, USA.
Amy A WhelessUniversity of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, USA.
Rebecca L GreenDepartment of Radiation Oncology, University of North Carolina, Chapel Hill, Chapel Hill, North Carolina, USA.
Julie M BenbowUniversity of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, USA.
E Claire DeesUniversity of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, USA Department of Medicine, University of North Carolina, Chapel Hill, Chapel Hill, North Carolina, USA.
Lisa A CareyUniversity of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, USA Department of Medicine, University of North Carolina, Chapel Hill, Chapel Hill, North Carolina, USA.
Matthew G EwendUniversity of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, USA Department of Neurosurgery, University of North Carolina, Chapel Hill, Chapel Hill, North Carolina, USA.
Carey K AndersUniversity of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, USA Department of Medicine, University of North Carolina, Chapel Hill, Chapel Hill, North Carolina, USA carey_anders@med.unc.edu.
Timothy M ZagarUniversity of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, USA Department of Radiation Oncology, University of North Carolina, Chapel Hill, Chapel Hill, North Carolina, USA Department of Neurosurgery, University of North Carolina, Chapel Hill, Chapel Hill, North Carolina, USA.
UNC Lineberger Comprehensive Cancer CenterUniversity of North Carolina at Chapel Hill · US

Funding

Virology Research Program (Program 4)P30CA016086 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Deborah F. Tate · 1985 to 2026
$201.5M
Tissue Procurement & PathologyP50CA058223 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI KATHERINE A. HOADLEY · 1992 to 2026
$59.3M
UNC-CH CENTER FOR ENVIRONMENTAL HEALTH &SUSCEPTIBILITYP30ES010126 · NIEHS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Melissa A. Troester · 2001 to 2026
$36.3M
PARP Inhibition to Treat Triple-Negative Breast Cancer Brain MetastasesK23CA157728 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI ANDERS, CAREY KERNODLE · 2011 to 2015
$867k
NCI NIH HHS 2-P50-CA058223-20NCI NIH HHS K23 CA157728NCI NIH HHS K23CA157728NCI NIH HHS P30 CA016086NCI NIH HHS P50 CA058223NIEHS NIH HHS P30 ES010126
6 · The paper itself

Abstract

backgroundBreast cancer brain metastasis (BCBM) confers a poor prognosis and is unusual in requiring multidisciplinary care in the metastatic setting. The University of North Carolina at Chapel Hill (UNC-CH) has created a BCBM clinic to provide medical and radiation oncology, neurosurgical, and supportive services to this complex patient population. We describe organization and design of the clinic as well as characteristics, treatments, and outcomes of the patients seen in its first 3 years.

methodsClinical and demographic data were collected from patients in a prospectively maintained database. Descriptive statistics are reported as percentages and means. The Kaplan-Meier method was used to estimate time-to-event outcomes.

resultsSixty-five patients were seen between January 2012 and January 2015. At the time of presentation to the BCBM clinic, most patients (74%) had multiple (≥2) brain metastases and had received prior systemic (77%) and whole-brain radiation therapy and/or central nervous system stereotactic radiosurgery (65%) in the metastatic setting. Seventy-eight percent returned for a follow-up visit; 32% were enrolled in a clinical trial. Median time from diagnosis of brain metastasis to death was 2.11 years (95% confidence interval [CI] 1.31-2.47) for all patients, 1.15 years (95% CI 0.4-2.43) for triple-negative breast cancer, 1.31 years (95% CI 0.51-2.52) for hormone receptor-positive/HER2- breast cancer, and 3.03 years (95% CI lower limit 1.94, upper limit not estimable) for HER2+ breast cancer (p = .0037).

conclusionPatients with BCBM have unique and complex needs that require input from several oncologic disciplines. The development of the UNC-CH multidisciplinary BCBM clinic is a model that can be adapted at other centers to provide coordinated care for patients with a challenging and complex disease. IMPLICATIONS FOR PRACTICE: Patients with breast cancer brain metastases often require unique multidisciplinary care to meet the numerous and uncommon challenges associated with their conditions. Here, the development and characteristics of a clinic designed specifically to provide for the multidisciplinary needs of patients with breast cancer brain metastases are described. This clinic may serve as a model for other institutions interested in creating specialty clinics with similar objectives.

Indexed as

PrognosisRadiosurgeryAdultAgedBrain NeoplasmsBreast NeoplasmsCombined Modality TherapyFemaleHumansKaplan-Meier EstimateMiddle AgedNeoplasm MetastasisNorth CarolinaTreatment OutcomeBrain metastasesBreast cancerClinicMultidisciplinary

Identifiers

PMID26659221
PMCPMC4709216
OpenAlexW2204583590

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.